Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 28, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Current Deferred Tax Assets (2010 - 2024)

Updated

Sinovac Biotech's Current Deferred Tax Assets was $338,000 in Q2 2017.

Analysis

Sinovac Biotech (SVA) Current Deferred Tax Assets (2010 - 2024) Analysis & Trends

At the end of FY2016, Current Deferred Tax Assets at Sinovac Biotech came in at $3.49 million, up 34.2% from FY2015.

  • Current Deferred Tax Assets shows a three-year compound annual growth rate of 10.3% (FY2013 to FY2016).
  • In earlier years, Current Deferred Tax Assets was $2.6 million in FY2015 (+14.9%), $2.27 million in FY2014 (-12.9%) and $2.6 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Sinovac Biotech 464.94 Mn -24.98 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -68.90 Mn
Dec 31, 2023 -155.75 Mn
Dec 31, 2022 -90.56 Mn
Dec 31, 2021 -12.11 Mn
Jun 30, 2017 338,000.00
Dec 31, 2016 3.49 Mn
Dec 31, 2015 2.60 Mn
Dec 31, 2014 2.27 Mn
Dec 31, 2013 2.60 Mn
Dec 31, 2010 2.68 Mn
API Access

Sinovac Biotech Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=SVA&period=max&api_key=YOUR_API_KEY